SOURCE: DC Brands International, Inc.

November 29, 2007 10:30 ET

DC Brands Sales Team Heads to Phoenix

DENVER, CO--(Marketwire - November 29, 2007) - DC Brands International (PINKSHEETS: DCBR) announces today they have sent members of the sales team to Phoenix to meet with two retailers who received the Project F introductory package and have shown great interest.

The company's new sales team member Paddy Sheya said, "I would not make the trip if I did not believe there was business to be done down there. I expect to get commitments from both for right after the first of the year. This time of year is a real push to get buyers to respond, but I am very optimistic about both of these groups. One of them is already doing business with us here in Colorado and looking to expand based on the initial performance they have seen. The other is new and could provide several thousand new locations for us next year. We will provide an update when we return."

About DC Brands International:

DC Brands International, a publicly traded company under the ticker symbol (PINKSHEETS: DCBR), specializes in and manufactures unique energy drink brands. Established in 1998, DC Brands went public in 2005, and the company's first product, Dickens Energy Cider, launched in 2002 after a lengthy process in developing its distinctive flavor and packaging. Following the success of Dickens Energy Cider, the company chose to expand its product line with a beverage that filled the substantial NASCAR niche. With more than 75 million loyal fans, the NASCAR demographic presented an attractive opportunity to become one of the few racecar-themed energy drinks in the marketplace. Following much due diligence, research and testing, Turn Left Energy Drink recently came to fruition.

For more information on DC Brands International, visit their website at and

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information